Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
X Li, Q Yao, C Liu, J Wang, H Zhang… - Journal of …, 2022 - Taylor & Francis
Hepatocellular carcinoma is one of the most common malignancies globally. Recently, a
newly identified histological subtype, designated as “macrotrabecular-massive …
newly identified histological subtype, designated as “macrotrabecular-massive …
[HTML][HTML] Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
M Yao, JL Yang, DF Wang, L Wang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
The prevention, early discovery and effective treatment of patients with hepatocellular
carcinoma (HCC) remain a global medical challenge. At present, HCC is still mainly treated …
carcinoma (HCC) remain a global medical challenge. At present, HCC is still mainly treated …
[HTML][HTML] Changes in serum growth factors during lenvatinib predict the post progressive survival in patients with unresectable hepatocellular carcinoma
Z Yang, G Suda, O Maehara, M Ohara, S Yoshida… - Cancers, 2022 - mdpi.com
Simple Summary In this study, we firstly revealed that the pattern of developing resistance to
lenvatinib varies and determines the prognosis of patients with unresectable hepatocellular …
lenvatinib varies and determines the prognosis of patients with unresectable hepatocellular …
[HTML][HTML] Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma
L Song, C Xu, T Zhang, S Chen, S Hu, B Cheng… - Frontiers in …, 2022 - frontiersin.org
Background: Growing evidence suggests that infiltrating neutrophils are key players in
hepatocellular carcinoma (HCC) tumor progression. However, a comprehensive analysis of …
hepatocellular carcinoma (HCC) tumor progression. However, a comprehensive analysis of …
Metabolite profiling of a Sargassum micracanthum methanol extract with in vitro efficacy against human head and neck squamous cell carcinoma aggressiveness
MH Ahn, JA Shin, SO Yang, WS Choi, S Jang… - Archives of Oral …, 2022 - Elsevier
Objective Extracts from the brown algae Sargassum micracanthum have documented anti-
viral, anti-oxidant, and anti-inflammatory activities as well as potential anti-tumor efficacy …
viral, anti-oxidant, and anti-inflammatory activities as well as potential anti-tumor efficacy …
[PDF][PDF] Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma [J]. Cancers …
ZJ Yang, G Suda, O Maehara, M Ohara… - DOI: https://doi. org …, 2022 - academia.edu
Serum growth factor changes and their effect on prognosis during lenvatinib for
unresectable hepatocellular carcinoma (HCC) remain underexplored. The sequential …
unresectable hepatocellular carcinoma (HCC) remain underexplored. The sequential …
A phase I pharmacokinetic study of lenvatinib in Chinese patients with unresectable hepatocellular carcinoma
Y Bai, X Hu, Z Ren, T Hisai, W Yusa, L Weng… - Future …, 2022 - Taylor & Francis
Aim: This phase I study assessed the pharmacokinetic profile, safety and antitumor activity of
lenvatinib in Chinese patients with unresectable hepatocellular carcinoma. Materials & …
lenvatinib in Chinese patients with unresectable hepatocellular carcinoma. Materials & …